RELYPSA INC's ticker is RLYP and the CUSIP is 759531106. A total of 123 filers reported holding RELYPSA INC in Q1 2015. The put-call ratio across all filers is 2.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $8,559,000 | +40.7% | 462,649 | +3.1% | 0.07% | +22.0% |
Q1 2016 | $6,081,000 | +66.5% | 448,773 | +306.6% | 0.06% | +22.9% |
Q2 2015 | $3,652,000 | -47.1% | 110,372 | -42.3% | 0.05% | -46.7% |
Q1 2015 | $6,902,000 | +21.2% | 191,362 | +3.5% | 0.09% | +20.0% |
Q4 2014 | $5,693,000 | +1569.5% | 184,825 | +1042.6% | 0.08% | +1400.0% |
Q3 2014 | $341,000 | – | 16,176 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 8,857,551 | $186,806,000 | 1.95% |
Consonance Capital Management LP | 660,462 | $13,929,000 | 1.91% |
Perceptive Advisors | 762,705 | $16,085,000 | 1.73% |
AlpInvest Partners B.V. | 10,495 | $221,000 | 0.69% |
SECTORAL ASSET MANAGEMENT INC | 738,573 | $15,577,000 | 0.66% |
SOUTHPORT MANAGEMENT, L.L.C. | 22,500 | $475,000 | 0.59% |
Rock Springs Capital Management LP | 145,000 | $3,058,000 | 0.47% |
PFM Health Sciences, LP | 589,492 | $12,432,000 | 0.29% |
SPHERA FUNDS MANAGEMENT LTD. | 97,100 | $2,048,000 | 0.25% |
DOW CHEMICAL CO /DE/ | 69,899 | $1,474,000 | 0.13% |